A few years ago, during an international project S. Bačilūnas met A. Chwalibog, a participant from Poland, who was writing her university thesis on how psychobiotics can contribute to the treatment of various psychiatric diseases. The new acquaintance kept in touch, and a year later, they decided to set up a company together to develop psychobiotics and introduce them to the public.